TSL-1502

· Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TSL-1502, covering 2024-05-08 to 2024-05-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations [Phase 2]

See pricing